Integra LifeSciences Holdings (IART) Stock Price

IARTStock

$16.89+13.81%52W

Market Cap$1.31B

P/E—

PEG Ratio0.67

Div yield—

Beta1.22

IART Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)34.56%

Price vs S&P 500 (4W)-7.08%

PEG Ratio0.67

VGM Score49.89

P/CF (Annual)27.91x

Book Value / Share (Quarterly)$13.41

P/TBV (Annual)5.18x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.63%

Cash Flow / Share (Quarterly)$0.15

Price vs S&P 500 (YTD)23.17%

Gross Margin (TTM)57.24%

Net Profit Margin (TTM)-0.44%

EPS (TTM)$-0.10

10-Day Avg Trading Volume0.56M

EPS Excl Extra (TTM)$-0.10

Revenue Growth (5Y)3.57%

EPS (Annual)$-6.74

ROI (Annual)-17.81%

Gross Margin (Annual)56.62%

Net Profit Margin (5Y Avg)-1.01%

Cash / Share (Quarterly)$3.52

Revenue Growth QoQ (YoY)0.76%

ROA (Last FY)-14.34%

Revenue Growth TTM (YoY)1.60%

EBITD / Share (TTM)$1.04

ROE (5Y Avg)-5.13%

Operating Margin (TTM)3.96%

Cash Flow / Share (Annual)$-0.58

P/B Ratio1.35x

P/B Ratio (Quarterly)1.34x

Net Income / Employee (Annual)$-116,700

EV / Revenue (TTM)1.86x

Net Interest Coverage (TTM)-7.31x

ROA (TTM)-0.20%

EV / EBITDA (TTM)38.19x

EPS Incl Extra (Annual)$-6.74

Current Ratio (Annual)2.54x

Quick Ratio (Quarterly)1.80x

3-Month Avg Trading Volume0.96M

52-Week Price Return13.81%

EV / Free Cash Flow (Annual)16.19x

Revenue / Employee (TTM)$372,200

Tangible BV / Share (Quarterly)$4.33

P/S Ratio (Annual)0.86x

Asset Turnover (Annual)0.45x

52-Week High$20.49

Operating Margin (5Y Avg)1.78%

EPS Excl Extra (Annual)$-6.74

CapEx CAGR (5Y)8.40%

Tangible BV CAGR (5Y)-2.59%

26-Week Price Return46.49%

Quick Ratio (Annual)1.25x

13-Week Price Return2.61%

Total Debt / Equity (Annual)1.78x

Current Ratio (Quarterly)3.60x

Enterprise Value$3.06B

Revenue / Share Growth (5Y)5.78%

Asset Turnover (TTM)0.46x

Book Value / Share Growth (5Y)-5.70%

Revenue / Employee (Annual)$369,400

Inventory Turnover (Annual)1.54x

Pretax Margin (Annual)-34.46%

Cash / Share (Annual)$3.39

3-Month Return Std Dev58.93%

Gross Margin (5Y Avg)61.07%

Net Income / Employee (TTM)$-1,600

EBITDA CAGR (5Y)-17.88%

EBITDA Interim CAGR (5Y)-16.23%

ROE (Last FY)-49.50%

Net Interest Coverage (Annual)1.00x

EPS Basic Excl Extra (Annual)$-6.74

P/FCF (TTM)38.80x

Receivables Turnover (TTM)5.97x

EV / Free Cash Flow (TTM)264.14x

Total Debt / Equity (Quarterly)1.79x

EPS Incl Extra (TTM)$-0.10

Receivables Turnover (Annual)5.93x

ROI (TTM)-0.25%

P/S Ratio (TTM)0.85x

Pretax Margin (5Y Avg)-0.54%

Revenue / Share (Annual)$21.33

Tangible BV / Share (Annual)$4.38

Forward P/E6.73x

Free OCF CAGR (5Y)-31.13%

Price vs S&P 500 (52W)-4.74%

Year-to-Date Return35.99%

5-Day Price Return1.20%

EPS Normalized (Annual)$-6.74

ROA (5Y Avg)-0.72%

Net Profit Margin (Annual)-31.58%

Month-to-Date Return1.44%

Cash Flow / Share (TTM)$2.73

EBITD / Share (Annual)$-6.26

Operating Margin (Annual)-30.25%

LT Debt / Equity (Annual)1.66x

P/CF (TTM)16.48x

ROI (5Y Avg)-1.01%

LT Debt / Equity (Quarterly)1.75x

EPS Basic Excl Extra (TTM)$-0.10

P/TBV (Quarterly)5.05x

P/B Ratio (Annual)0.93x

Inventory Turnover (TTM)1.47x

Pretax Margin (TTM)-0.01%

Book Value / Share (Annual)$13.40

Price vs S&P 500 (13W)0.66%

Beta1.22x

P/FCF (Annual)93.67x

Revenue / Share (TTM)$21.08

ROE (TTM)-0.70%

52-Week Low$8.70

vGradeB

gGradeD

mGradeB

vgmGradeC

IART Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	$0.48	$0.56	+16.50%(+$0.08)
Q1 2026	May 5, 2026	$0.40	$0.54	+33.36%(+$0.14)
Q4 2025	Feb 26, 2026	$0.80	$0.83	+3.73%(+$0.03)
Q3 2025	Oct 30, 2025	$0.43	$0.54	+24.30%(+$0.11)
Q2 2025	Jul 31, 2025	$0.43	$0.45	+4.38%(+$0.02)

IART Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.63

2.73

3.63

3.56

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Integra LifeSciences Holdings

Integra Lifesciences Holdings Corp is a New Jersey-based medical devices company specializing in regenerative therapy, extremity orthopedics, and neurosurgical solutions. The company operates through two main segments—Codman Specialty Surgical, which generates the majority of revenue, and Tissue Technologies—with a global presence spanning North America, Europe, and Asia Pacific, supported by substantial U.S. market sales.